Рынок левожелудочковых вспомогательных устройств (LVAD) в Азиатско-Тихоокеанском регионе по типу продукта (сердечный насос, контроллер, батареи, провода), терапия (терапия моста к трансплантации (BTT), терапия места назначения, терапия моста к кандидату (BTC), терапия моста к восстановлению (BTR)), возрастная группа (взрослые, дети), показания (застойная сердечная недостаточность, врожденный порок сердца , миокардит, остановка сердца, семейные аритмии и аритмии, кардиомиопатии, прогрессирующая сердечная недостаточность, другие), поколение (устройства второго поколения, устройства третьего поколения, устройства первого поколения), долговечность (долгосрочная, среднесрочная, краткосрочная), конструкция (осевая, центробежная), тип импульса (непульсирующий, пульсирующий), конечный пользователь (больницы, катетеризация сердца) Лаборатории, специализированные клиники, другие), канал сбыта (прямые тендеры, розничные продажи, другие), страна (Китай, Южная Корея, Япония, Индия, Австралия, Сингапур, Малайзия, Индонезия, Таиланд, Филиппины, остальные страны Азиатско-Тихоокеанского региона). Тенденции развития отрасли и прогноз до 2029 года.
Анализ рынка и аналитика : Азиатско-Тихоокеанский рынок устройств поддержки левого желудочка (LVAD)
Ожидается, что рынок устройств поддержки левого желудочка (LVAD) будет расти в прогнозируемый период с 2022 по 2029 год. По данным Data Bridge Market Research, среднегодовой темп роста рынка составит 10,8% в прогнозируемый период с 2022 по 2029 год, и ожидается, что к 2029 году его объем достигнет 298,94 млн долларов США. Рост расходов на здравоохранение и рост распространенности заболеваний сердца являются движущими силами роста рынка устройств поддержки левого желудочка (LVAD).
Устройство поддержки левого желудочка (LVAD) — это насос, который мы используем для пациентов, достигших терминальной стадии сердечной недостаточности. Устройство поддержки левого желудочка имплантируется хирургическим путем и представляет собой работающий от батареи механический насос, который помогает левому желудочку перекачивать кровь в остальную часть крови. Устройства LVAD можно использовать в качестве моста к трансплантации, целевой терапии, моста к кандидатной терапии и моста к восстановительной терапии.
Changing lifestyle triggers the development of cardiovascular diseases which has enhanced the requirement of left ventricular assist device (LVAD) products which improves patient outcomes and allows them to lead a better life hence acts as driver for the left ventricular assist device (LVAD) market. The complications and risks associated with LVAD and presence of alternative approaches including heart transplantation is expected to hinder the growth of left ventricular assist device (LVAD) market growth. Increase in healthcare expenditure and increase in minimally invasive procedure, thus acts as an opportunity for the left ventricular assist device (LVAD) market. Increase in product recall pose a serious safety risk to the public restrict the product manufacturers to earn potential benefit in the market and impacts the overall market size, hence acts as challenge for the left ventricular assist device (LVAD) market growth.
The left ventricular assist device (LVAD) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Left Ventricular Assist Device (LVAD) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Left Ventricular Assist Device (LVAD) Market Scope and Market Size
The left ventricular assist device (LVAD) market is segmented on the based on the product type, therapy, age group, indication, generation, durability, design, pulse type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the left ventricular assist device (LVAD) market is segmented into heart pump, controller, batteries and wires. In 2022, heart pump segment is expected to dominate the left ventricular assist device (LVAD) market as heart pumps ensures the proper and vital functioning of left ventricular assist devices and enhances the patient satisfaction suffering from heart failure. Moreover, increasing number of heart failure is also accelerating the market growth.
- On the basis of therapy, the left ventricular assist device (LVAD) market is segmented into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-candidacy (BTC) therapy, bridge-to-recovery (BTR) therapy. In 2022, bridge-to-transplant (BTT) therapy is expected to dominate the market as it is applicable to patients wait for further transplantation and also improves the quality of patients life as it pumps oxygen enriched blood.
- На основе возрастной группы рынок устройств поддержки левого желудочка (LVAD) сегментирован на взрослый и детский. Ожидается, что в 2022 году на рынке будут доминировать взрослые из-за увеличения гериатрического населения, поскольку сердечная недостаточность в основном поражает взрослое население в возрасте от 55 до 75 лет.
- На основе показаний рынок устройств вспомогательного кровообращения левого желудочка (LVAD) сегментируется на застойную сердечную недостаточность, врожденные пороки сердца, миокардит , остановку сердца, семейные аритмии и аритмии, кардиомиопатии, прогрессирующую сердечную недостаточность и др. Ожидается, что в 2022 году сегмент застойной сердечной недостаточности будет доминировать на рынке из-за растущего ожирения, которое приводит к высокому уровню сердечных недостаточностей.
- На основе поколения рынок устройств поддержки левого желудочка (LVAD) сегментируется на устройства второго поколения, устройства третьего поколения и устройства первого поколения. Ожидается, что в 2022 году сегмент устройств второго поколения будет доминировать на рынке, поскольку большинство устройств поддержки левого желудочка, доступных на рынке, относятся ко второму поколению, и эти меньшие устройства обеспечивают легкую имплантацию с низким уровнем инфекций привода по сравнению с устройствами первого поколения.
- На основе долговечности рынок устройств поддержки левого желудочка (LVAD) сегментируется на долгосрочные, среднесрочные и краткосрочные. Ожидается, что в 2022 году долгосрочный сегмент будет доминировать на рынке, поскольку эти устройства выступают в качестве альтернативной терапии для предотвращения пациентов, страдающих от сердечной недостаточности.
- На основе конструкции рынок устройств поддержки левого желудочка (LVAD) сегментируется на аксиальные и центробежные. Ожидается, что в 2022 году аксиальный сегмент будет доминировать на рынке, поскольку они были впервые одобрены на рынке и до сих пор используются несколькими производителями при проектировании LVAD. Более того, аксиальный сегмент улучшает качество жизни пациента, особенно у пациентов, переживших периоперационный период.
- На основе типа импульса рынок устройств поддержки левого желудочка (LVAD) сегментируется на непульсирующие и пульсирующие. Ожидается, что в 2022 году сегмент непульсирующих устройств будет доминировать на рынке, поскольку это насосы LVAD с непрерывным потоком, которые, в свою очередь, улучшают функциональные преимущества сердца у пациентов, страдающих терминальной стадией сердечной недостаточности.
- На основе конечного пользователя рынок устройств поддержки левого желудочка (LVAD) сегментируется на больницы, специализированные клиники, лаборатории катетеризации сердца и т. д. Ожидается, что в 2022 году сегмент больниц будет доминировать на рынке из-за доступности технологически продвинутых устройств поддержки левого желудочка и наличия обученных медицинских работников.
- На основе канала сбыта рынок устройств поддержки левого желудочка (LVAD) сегментируется на прямые торги, розничные продажи и другие. Ожидается, что в 2022 году сегмент прямых торгов будет доминировать на рынке, поскольку прямые торги предлагают высококачественные устройства поддержки левого желудочка экономически эффективным способом.
Анализ рынка левожелудочкового вспомогательного устройства (LVAD) на уровне страны
Проведен анализ рынка устройств вспомогательного кровообращения левого желудочка (LVAD), а также предоставлена информация о размере рынка по стране, типу продукта, терапии, возрастной группе, показанию, поколению, долговечности, конструкции, типу импульса, конечному пользователю и каналу сбыта, как указано выше.
В отчете о рынке устройств поддержки левого желудочка (LVAD) рассматриваются следующие страны: Китай, Южная Корея, Япония, Индия, Австралия, Сингапур, Малайзия, Индонезия, Таиланд, Филиппины и остальные страны Азиатско-Тихоокеанского региона.
Ожидается, что сегмент сердечных насосов в Азиатско-Тихоокеанском регионе будет расти самыми высокими темпами в прогнозируемый период с 2022 по 2029 год из-за увеличения населения, подверженного хроническим сердечно-сосудистым заболеваниям. Сегмент сердечных насосов в Японии доминирует на азиатско-тихоокеанском рынке устройств поддержки левого желудочка (LVAD) из-за растущего технологического прогресса и увеличения случаев терминальной стадии сердечной недостаточности.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, замещающие продажи, демографические данные страны, нормативные акты и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность глобальных брендов и их проблемы из-за большой или малой конкуренции со стороны местных и отечественных брендов, влияние каналов продаж.
Благоприятная политика возмещения расходов увеличила спрос на лечение сердечных заболеваний с помощью LVAD, а увеличение числа запусков продукции стимулирует рост рынка устройств поддержки левого желудочка (LVAD)
Рынок левожелудочковых вспомогательных устройств (LVAD) также предоставляет вам подробный анализ рынка для роста каждой страны на определенном рынке. Кроме того, он предоставляет подробную информацию о стратегии участников рынка и их географическом присутствии. Данные доступны за исторический период с 2011 по 2020 год.
Анализ конкурентной среды и доли рынка устройств вспомогательного кровообращения левого желудочка (LVAD)
Конкурентная среда рынка левожелудочковых вспомогательных устройств (LVAD) содержит сведения по конкурентам. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, производственные площадки и объекты, сильные и слабые стороны компании, запуск продукта, испытания продуктов, одобрения продуктов, патенты, широта и широта продукта, доминирование приложений, кривая жизненной линии технологий. Приведенные выше данные относятся только к фокусу компании, связанному с рынком левожелудочковых вспомогательных устройств (LVAD).
Основными компаниями, работающими в области левожелудочкового вспомогательного устройства (LVAD), являются Abbott, Evaheart, Inc, Saft (дочерняя компания TotalEnergies), ABIOMED, Berlin Heart, CorWave SA, Jarvik Heart, Inc. и другие отечественные игроки. Аналитики DBMR понимают конкурентные преимущества и предоставляют конкурентный анализ для каждого конкурента отдельно.
Запуск новой программы по разработке современных устройств для коррекции левого желудочка в странах Азиатско-Тихоокеанского региона ускоряет развитие рынка устройств поддержки левого желудочка (LVAD).
Например,
- В феврале 2021 года IIT-Kanpur запустил проект по разработке усовершенствованного искусственного левого желудочкового вспомогательного устройства в сотрудничестве с ведущими больницами страны. Эта программа была запущена не только для обогащения экосистемы здравоохранения страны, но и для повышения инноваций и улучшения биомедицинских исследований.
Сотрудничество, запуск продукции, расширение бизнеса, награды и признание, совместные предприятия и другие стратегии участников рынка расширяют присутствие компании на рынке устройств поддержки левого желудочка (LVAD), что также обеспечивает рост прибыли организации.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S
4.3 INDUSTRIAL INSIGHTS:
5 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: REGULATIONS
5.1 REGULATION IN U.S.
5.1.1 GUIDELINES-
5.2 REGULATION IN EUROPE
5.2.1 GUIDELINES FOR THE MANUFACTURERS:
5.3 REGULATION IN CANADA
5.3.1 GUIDELINES FOR THE MANUFACTURERS:
5.4 REGULATION IN MEXICO
5.4.1 GUIDELINES FOR THE MANUFACTURERS:
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING GERIATRIC POPULATION ALONG WITH RISING PREVALENCE OF CARDIAC DISEASES
6.1.2 PRESENCE OF FAVOURABLE REIMBURSEMENT POLICIES
6.1.3 CHANGING LIFESTYLE TRIGGERS THE DEVELOPMENT OF CARDIOVASCULAR DISEASES
6.2 RESTRAINTS
6.2.1 HIGH COST OF LVAD IMPLANTATION AND TREATMENT
6.2.2 COMPLICATIONS AND RISKS ASSOCIATED WITH LVAD
6.3 OPPORTUNITIES
6.3.1 INCREASE IN HEALTHCARE EXPENDITURE
6.3.2 INCREASE IN MINIMALLY INVASIVE PROCEDURE
6.3.3 INCREASING SHORTAGE OF ORGAN DONORS
6.3.4 TECHNOLOGICAL ADVANCEMENTS IN LEFT VENTRICULAR ASSIST DEVICES
6.4 CHALLENGES
6.4.1 ONGOING COVID-19
6.4.2 INCREASE IN PRODUCT RECALL
7 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 HEART PUMP
7.3 CONTROLLER
7.4 BATTERIES
7.4.1 RECHARGEABLE
7.4.2 NON-RECHARGEABLE
7.5 WIRES
8 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY
8.1 OVERVIEW
8.2 BRIDGE-TO-TRANSPLANT (BTT) THERAPY
8.2.1 HEART PUMP
8.2.2 CONTROLLER
8.2.3 BATTERIES
8.2.4 WIRES
8.3 DESTINATION THERAPY
8.3.1 HEART PUMP
8.3.2 CONTROLLER
8.3.3 BATTERIES
8.3.4 WIRES
8.4 BRIDGE-TO-CANDIDACY (BTC) THERAPY
8.4.1 HEART PUMP
8.4.2 CONTROLLER
8.4.3 BATTERIES
8.4.4 WIRES
8.5 BRIDGE-TO-RECOVERY (BTR) THERAPY
8.5.1 HEART PUMP
8.5.2 CONTROLLER
8.5.3 BATTERIES
8.5.4 WIRES
9 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP
9.1 OVERVIEW
9.2 ADULT
9.2.1 19-39 YEARS
9.2.2 40-59 YEARS
9.2.3 60-79 YEARS
9.2.4 ABOVE 80 YEARS
9.3 PEDIATRIC
10 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION
10.1 OVERVIEW
10.2 SECOND GENERATION DEVICES
10.3 THIRD GENERATION DEVICES
10.4 FIRST GENERATION DEVICES
11 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN
11.1 OVERVIEW
11.2 AXIAL
11.3 CENTRIFUGAL
12 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION
12.1 OVERVIEW
12.2 CONGESTIVE HEART FAILURE
12.2.1 HEART PUMP
12.2.2 CONTROLLER
12.2.3 BATTERIES
12.2.4 WIRES
12.3 CONGENITAL HEART DISEASE
12.3.1 HEART PUMP
12.3.2 CONTROLLER
12.3.3 BATTERIES
12.3.4 WIRES
12.4 MYOCARDITIS
12.4.1 HEART PUMP
12.4.2 CONTROLLER
12.4.3 BATTERIES
12.4.4 WIRES
12.5 CARDIAC ARREST
12.5.1 HEART PUMP
12.5.2 CONTROLLER
12.5.3 BATTERIES
12.5.4 WIRES
12.6 FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES
12.6.1 HEART PUMP
12.6.2 CONTROLLER
12.6.3 BATTERIES
12.6.4 WIRES
12.7 ADVANCED HEART FAILURE
12.7.1 HEART PUMP
12.7.2 CONTROLLER
12.7.3 BATTERIES
12.7.4 WIRES
12.8 OTHERS
13 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DURABILITY
13.1 OVERVIEW
13.2 LONG-TERM
13.3 INTERMEDIATE-TERM
13.4 SHORT-TERM
14 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY PULSE TYPE
14.1 OVERVIEW
14.2 NONPULSATILE
14.3 PULSATILE
15 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITAL
15.3 CARDIAC CATH LABORATORIES
15.4 SPECIALTY CLINICS
15.5 OTHERS
16 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 RETAIL SALES
16.4 OTHERS
17 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION
17.1 ASIA-PACIFIC
17.1.1 JAPAN
17.1.2 CHINA
17.1.3 SOUTH KOREA
17.1.4 INDIA
17.1.5 AUSTRALIA
17.1.6 SINGAPORE
17.1.7 THAILAND
17.1.8 MALAYSIA
17.1.9 PHILIPPINES
17.1.10 INDONESIA
17.1.11 REST OF ASIA-PACIFIC
18 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 ABIOMED
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.1.5.1 FDA APPROVAL
20.1.5.2 FDA APPROVAL
20.2 ABBOTT
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENTS
20.2.5.1 SUPPLY INCREMENT
20.2.5.2 BREAK THROUGH DEVICE DESIGNATION
20.3 BERLIN HEART
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.3.4.1 PRODUCT APPROVAL
20.4 SAFT (A SUBSIDIARY OF TOTALENERGIES)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 COMPANY SHARE ANALYSIS
20.4.4 PRODUCT PORTFOLIO
20.4.5 RECENT DEVELOPMENT
20.4.5.1 PARTNERSHIP
20.5 JARVIK HEART, INC.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.5.4.1 FDA APPROVAL
20.6 CORWAVE SA
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.6.3.1 EXPANSION
20.7 EVAHEART, INC
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.7.3.1 PRODUCT TRIAL
21 QUESTIONNAIRE
22 RELATED REPORTS
Список таблиц
TABLE 1 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC HEART PUMP IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC CONTROLLER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC WIRES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC PEDIATRIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC SECOND GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC THIRD GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC FIRST GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC AXIAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC CENTRIFUGAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 36 ASIA PACIFIC FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 ASIA PACIFIC FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 38 ASIA PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 40 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC LONG TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 ASIA PACIFIC INTERMEDIATE-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 ASIA PACIFIC SHORT-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 45 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC NONPULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 ASIA PACIFIC PULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 ASIA PACIFIC HOSPITALS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC CARDIAC CATH LABORATORIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 ASIA PACIFIC SPECIALTY CLINICS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 54 ASIA PACIFIC DIRECT TENDER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 ASIA PACIFIC RETAIL SALES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 56 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 57 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 58 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 59 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 60 ASIA-PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 61 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 62 ASIA-PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 63 ASIA-PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 64 ASIA-PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 65 ASIA-PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 66 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 67 ASIA-PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 68 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 69 ASIA-PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 70 ASIA-PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 71 ASIA-PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 72 ASIA-PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 73 ASIA-PACIFIC FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 74 ASIA-PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 75 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 76 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 77 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 78 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 79 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 80 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 81 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 82 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 83 JAPAN BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 84 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 85 JAPAN BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 86 JAPAN DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 87 JAPAN BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 88 JAPAN BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 89 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 90 JAPAN ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 91 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 92 JAPAN CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 93 JAPAN CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 94 JAPAN MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 95 JAPAN CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 96 JAPAN FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 97 JAPAN ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 98 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 99 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 100 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 101 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 102 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 103 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 104 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 105 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 106 CHINA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 107 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 108 CHINA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 109 CHINA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 110 CHINA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 111 CHINA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 112 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 113 CHINA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 114 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 115 CHINA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 116 CHINA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 117 CHINA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 118 CHINA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 119 CHINA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 120 CHINA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 121 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 122 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 123 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 124 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 125 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 126 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 127 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 128 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 129 SOUTH KOREA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 130 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 131 SOUTH KOREA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 132 SOUTH KOREA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 133 SOUTH KOREA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 134 SOUTH KOREA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 135 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 136 SOUTH KOREA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 137 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 138 SOUTH KOREA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 139 SOUTH KOREA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 140 SOUTH KOREA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 141 SOUTH KOREA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 142 SOUTH KOREA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 143 SOUTH KOREA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 144 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 145 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 146 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 147 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 148 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 149 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 150 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 151 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 152 INDIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 153 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 154 INDIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 155 INDIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 156 INDIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 157 INDIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 158 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 159 INDIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 160 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 161 INDIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 162 INDIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 163 INDIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 164 INDIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 165 INDIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 166 INDIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 167 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 168 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 169 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 170 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 171 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 172 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 173 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 174 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 175 AUSTRALIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 176 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 177 AUSTRALIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 178 AUSTRALIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 179 AUSTRALIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 180 AUSTRALIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 181 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 182 AUSTRALIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 183 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 184 AUSTRALIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 185 AUSTRALIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 186 AUSTRALIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 187 AUSTRALIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 188 AUSTRALIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 189 AUSTRALIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 190 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 191 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 192 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 193 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 194 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 195 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 196 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 197 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 198 SINGAPORE BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 199 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 200 SINGAPORE BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 201 SINGAPORE DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 202 SINGAPORE BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 203 SINGAPORE BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 204 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 205 SINGAPORE ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 206 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 207 SINGAPORE CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 208 SINGAPORE CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 209 SINGAPORE MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 210 SINGAPORE CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 211 SINGAPORE FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 212 SINGAPORE ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 213 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 214 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 215 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 216 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 217 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 218 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 219 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 220 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 221 THAILAND BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 222 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 223 THAILAND BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 224 THAILAND DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 225 THAILAND BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 226 THAILAND BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 227 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 228 THAILAND ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 229 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 230 THAILAND CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 231 THAILAND CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 232 THAILAND MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 233 THAILAND CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 234 THAILAND FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 235 THAILAND ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 236 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 237 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 238 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 239 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 240 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 241 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 242 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 243 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 244 MALAYSIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 245 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 246 MALAYSIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 247 MALAYSIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 248 MALAYSIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 249 MALAYSIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 250 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 251 MALAYSIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 252 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 253 MALAYSIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 254 MALAYSIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 255 MALAYSIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 256 MALAYSIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 257 MALAYSIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 258 MALAYSIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 259 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 260 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 261 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 262 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 263 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 264 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 265 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 266 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 267 PHILIPPINES BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 268 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 269 PHILIPPINES BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 270 PHILIPPINES DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 271 PHILIPPINES BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 272 PHILIPPINES BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 273 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 274 PHILIPPINES ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 275 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 276 PHILIPPINES CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 277 PHILIPPINES CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 278 PHILIPPINES MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 279 PHILIPPINES CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 280 PHILIPPINES FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 281 PHILIPPINES ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 282 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 283 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 284 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 285 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 286 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 287 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 288 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 289 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)
TABLE 290 INDONESIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 291 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 292 INDONESIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 293 INDONESIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 294 INDONESIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 295 INDONESIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)
TABLE 296 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 297 INDONESIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 298 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 299 INDONESIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 300 INDONESIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 301 INDONESIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 302 INDONESIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 303 INDONESIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 304 INDONESIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 305 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)
TABLE 306 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)
TABLE 307 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 308 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)
TABLE 309 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 310 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 311 REST OF ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
Список рисунков
FIGURE 1 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: ASIA PACIFIC VS REGIONAL ANALYSIS
FIGURE 5 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: END USER COVERAGE GRID
FIGURE 9 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET:VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASE AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 HEART PUMP SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET AND ASIA-PACIFIC TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET
FIGURE 15 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 17 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2021
FIGURE 20 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, 2020-2029 (USD MILLION)
FIGURE 21 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, CAGR (2022-2029)
FIGURE 22 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY THERAPY, LIFELINE CURVE
FIGURE 23 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2021
FIGURE 24 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, 2020-2029 (USD MILLION)
FIGURE 25 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 26 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 27 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2021
FIGURE 28 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, 2020-2029 (USD MILLION)
FIGURE 29 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, CAGR (2022-2029)
FIGURE 30 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY GENERATION, LIFELINE CURVE
FIGURE 31 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2021
FIGURE 32 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 33 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 34 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 35 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2021
FIGURE 36 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, 2020-2029 (USD MILLION)
FIGURE 37 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, CAGR (2022-2029)
FIGURE 38 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 39 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2021
FIGURE 40 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, 2020-2029 (USD MILLION)
FIGURE 41 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, CAGR (2022-2029)
FIGURE 42 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DURABILITY, LIFELINE CURVE
FIGURE 43 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2021
FIGURE 44 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, 2020-2029 (USD MILLION)
FIGURE 45 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, CAGR (2022-2029)
FIGURE 46 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY PULSE TYPE, LIFELINE CURVE
FIGURE 47 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2021
FIGURE 48 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 49 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, CAGR (2022-2029)
FIGURE 50 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY END USER, LIFELINE CURVE
FIGURE 51 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 52 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 53 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 54 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 55 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: SNAPSHOT (2021)
FIGURE 56 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021)
FIGURE 57 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2022 & 2029)
FIGURE 58 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY COUNTRY (2021 & 2029)
FIGURE 59 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 60 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET: COMPANY SHARE 2021 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
